Last Name First Name Research/Clinical Interest Title Keywords   MILLER C. RYAN Glioma pathogenesis and preclinical experimental therapeutics glioma, glioblastoma, mouse models, genomics, proteomics   MILLER C. RYAN Glioma pathogenesis and preclinical experimental therapeutics glioma, glioblastoma, mouse models, genomics, proteomics   MILLER C. RYAN Glioma pathogenesis and preclinical experimental therapeutics glioma, glioblastoma, mouse models, genomics, proteomics   MOBLEY JAMES Director, UAB CCC Mass Spectrometry/ Proteomics Shared Facility Cancer, Prostate, Pancreatic, Breast, Biomarkers, Mass Spectrometry   MOBLEY JAMES Director, UAB CCC Mass Spectrometry/ Proteomics Shared Facility Cancer, Prostate, Pancreatic, Breast, Biomarkers, Mass Spectrometry   MOBLEY JAMES Director, UAB CCC Mass Spectrometry/ Proteomics Shared Facility Cancer, Prostate, Pancreatic, Breast, Biomarkers, Mass Spectrometry   MOBLEY JAMES Director, UAB CCC Mass Spectrometry/ Proteomics Shared Facility Cancer, Prostate, Pancreatic, Breast, Biomarkers, Mass Spectrometry   MOHAMED ISMAIL Functional imaging in pediatric epilepsy Epilepsy surgery, functional mapping, Magnetoencephalography, computational neuroscience   MOHAMED ISMAIL Functional imaging in pediatric epilepsy Epilepsy surgery, functional mapping, Magnetoencephalography, computational neuroscience   MOHAMED ISMAIL Functional imaging in pediatric epilepsy Epilepsy surgery, functional mapping, Magnetoencephalography, computational neuroscience   MOLDOVEANU ZINA   MORROW CASEY Role of the Microbiome in Health and Disease Microbiome Management, Dysbiosis, NextGen DNA sequencing, Bioinformatics, Fecal Transplants, Cancer Metabolism, Drug/Antibiotic Impact On the Microbiome   MORROW CASEY Role of the Microbiome in Health and Disease Microbiome Management, Dysbiosis, NextGen DNA sequencing, Bioinformatics, Fecal Transplants, Cancer Metabolism, Drug/Antibiotic Impact On the Microbiome   MORROW CASEY Role of the Microbiome in Health and Disease Microbiome Management, Dysbiosis, NextGen DNA sequencing, Bioinformatics, Fecal Transplants, Cancer Metabolism, Drug/Antibiotic Impact On the Microbiome   MORROW CASEY Role of the Microbiome in Health and Disease Microbiome Management, Dysbiosis, NextGen DNA sequencing, Bioinformatics, Fecal Transplants, Cancer Metabolism, Drug/Antibiotic Impact On the Microbiome   MORROW CASEY Role of the Microbiome in Health and Disease Microbiome Management, Dysbiosis, NextGen DNA sequencing, Bioinformatics, Fecal Transplants, Cancer Metabolism, Drug/Antibiotic Impact On the Microbiome   MORROW CASEY Role of the Microbiome in Health and Disease Microbiome Management, Dysbiosis, NextGen DNA sequencing, Bioinformatics, Fecal Transplants, Cancer Metabolism, Drug/Antibiotic Impact On the Microbiome   MORROW CASEY Role of the Microbiome in Health and Disease Microbiome Management, Dysbiosis, NextGen DNA sequencing, Bioinformatics, Fecal Transplants, Cancer Metabolism, Drug/Antibiotic Impact On the Microbiome   MORROW CASEY Role of the Microbiome in Health and Disease Microbiome Management, Dysbiosis, NextGen DNA sequencing, Bioinformatics, Fecal Transplants, Cancer Metabolism, Drug/Antibiotic Impact On the Microbiome   MORROW CASEY Role of the Microbiome in Health and Disease Microbiome Management, Dysbiosis, NextGen DNA sequencing, Bioinformatics, Fecal Transplants, Cancer Metabolism, Drug/Antibiotic Impact On the Microbiome   MORROW CASEY Role of the Microbiome in Health and Disease Microbiome Management, Dysbiosis, NextGen DNA sequencing, Bioinformatics, Fecal Transplants, Cancer Metabolism, Drug/Antibiotic Impact On the Microbiome   MORROW CASEY Role of the Microbiome in Health and Disease Microbiome Management, Dysbiosis, NextGen DNA sequencing, Bioinformatics, Fecal Transplants, Cancer Metabolism, Drug/Antibiotic Impact On the Microbiome   MORROW CASEY Role of the Microbiome in Health and Disease Microbiome Management, Dysbiosis, NextGen DNA sequencing, Bioinformatics, Fecal Transplants, Cancer Metabolism, Drug/Antibiotic Impact On the Microbiome   MOUNTZ JOHN autoimmunity, immune senescence, gene therapy type I IFNs, IL-23, germinal centers, marginal zone macrophages, inflammatory macrophages, rheumatoid arthritis, lupus   MOUNTZ JOHN autoimmunity, immune senescence, gene therapy type I IFNs, IL-23, germinal centers, marginal zone macrophages, inflammatory macrophages, rheumatoid arthritis, lupus   MOUNTZ JOHN autoimmunity, immune senescence, gene therapy type I IFNs, IL-23, germinal centers, marginal zone macrophages, inflammatory macrophages, rheumatoid arthritis, lupus   MOUNTZ JOHN autoimmunity, immune senescence, gene therapy type I IFNs, IL-23, germinal centers, marginal zone macrophages, inflammatory macrophages, rheumatoid arthritis, lupus   MOUNTZ JOHN autoimmunity, immune senescence, gene therapy type I IFNs, IL-23, germinal centers, marginal zone macrophages, inflammatory macrophages, rheumatoid arthritis, lupus   MOUNTZ JOHN autoimmunity, immune senescence, gene therapy type I IFNs, IL-23, germinal centers, marginal zone macrophages, inflammatory macrophages, rheumatoid arthritis, lupus   MOUNTZ JOHN autoimmunity, immune senescence, gene therapy type I IFNs, IL-23, germinal centers, marginal zone macrophages, inflammatory macrophages, rheumatoid arthritis, lupus   MOUNTZ JOHN autoimmunity, immune senescence, gene therapy type I IFNs, IL-23, germinal centers, marginal zone macrophages, inflammatory macrophages, rheumatoid arthritis, lupus   MOUNTZ JOHN autoimmunity, immune senescence, gene therapy type I IFNs, IL-23, germinal centers, marginal zone macrophages, inflammatory macrophages, rheumatoid arthritis, lupus   MOUNTZ JOHN autoimmunity, immune senescence, gene therapy type I IFNs, IL-23, germinal centers, marginal zone macrophages, inflammatory macrophages, rheumatoid arthritis, lupus   MOUNTZ JOHN autoimmunity, immune senescence, gene therapy type I IFNs, IL-23, germinal centers, marginal zone macrophages, inflammatory macrophages, rheumatoid arthritis, lupus   MOUNTZ JOHN autoimmunity, immune senescence, gene therapy type I IFNs, IL-23, germinal centers, marginal zone macrophages, inflammatory macrophages, rheumatoid arthritis, lupus   MOUNTZ JOHN autoimmunity, immune senescence, gene therapy type I IFNs, IL-23, germinal centers, marginal zone macrophages, inflammatory macrophages, rheumatoid arthritis, lupus   MOUNTZ JOHN autoimmunity, immune senescence, gene therapy type I IFNs, IL-23, germinal centers, marginal zone macrophages, inflammatory macrophages, rheumatoid arthritis, lupus   MOUNTZ JOHN autoimmunity, immune senescence, gene therapy type I IFNs, IL-23, germinal centers, marginal zone macrophages, inflammatory macrophages, rheumatoid arthritis, lupus   MOUNTZ JOHN autoimmunity, immune senescence, gene therapy type I IFNs, IL-23, germinal centers, marginal zone macrophages, inflammatory macrophages, rheumatoid arthritis, lupus   MOUNTZ JOHN autoimmunity, immune senescence, gene therapy type I IFNs, IL-23, germinal centers, marginal zone macrophages, inflammatory macrophages, rheumatoid arthritis, lupus   MOUNTZ JOHN autoimmunity, immune senescence, gene therapy type I IFNs, IL-23, germinal centers, marginal zone macrophages, inflammatory macrophages, rheumatoid arthritis, lupus   MOUNTZ JOHN autoimmunity, immune senescence, gene therapy type I IFNs, IL-23, germinal centers, marginal zone macrophages, inflammatory macrophages, rheumatoid arthritis, lupus   MOUNTZ JOHN autoimmunity, immune senescence, gene therapy type I IFNs, IL-23, germinal centers, marginal zone macrophages, inflammatory macrophages, rheumatoid arthritis, lupus   MOUNTZ JOHN autoimmunity, immune senescence, gene therapy type I IFNs, IL-23, germinal centers, marginal zone macrophages, inflammatory macrophages, rheumatoid arthritis, lupus   MOUNTZ JOHN autoimmunity, immune senescence, gene therapy type I IFNs, IL-23, germinal centers, marginal zone macrophages, inflammatory macrophages, rheumatoid arthritis, lupus   MOUNTZ JOHN autoimmunity, immune senescence, gene therapy type I IFNs, IL-23, germinal centers, marginal zone macrophages, inflammatory macrophages, rheumatoid arthritis, lupus   MOUNTZ JOHN autoimmunity, immune senescence, gene therapy type I IFNs, IL-23, germinal centers, marginal zone macrophages, inflammatory macrophages, rheumatoid arthritis, lupus   MOUNTZ JOHN autoimmunity, immune senescence, gene therapy type I IFNs, IL-23, germinal centers, marginal zone macrophages, inflammatory macrophages, rheumatoid arthritis, lupus   MOUNTZ JOHN autoimmunity, immune senescence, gene therapy type I IFNs, IL-23, germinal centers, marginal zone macrophages, inflammatory macrophages, rheumatoid arthritis, lupus   MOUNTZ JOHN autoimmunity, immune senescence, gene therapy type I IFNs, IL-23, germinal centers, marginal zone macrophages, inflammatory macrophages, rheumatoid arthritis, lupus   MOUNTZ JOHN autoimmunity, immune senescence, gene therapy type I IFNs, IL-23, germinal centers, marginal zone macrophages, inflammatory macrophages, rheumatoid arthritis, lupus   MOUNTZ JOHN autoimmunity, immune senescence, gene therapy type I IFNs, IL-23, germinal centers, marginal zone macrophages, inflammatory macrophages, rheumatoid arthritis, lupus   MOUNTZ JOHN autoimmunity, immune senescence, gene therapy type I IFNs, IL-23, germinal centers, marginal zone macrophages, inflammatory macrophages, rheumatoid arthritis, lupus   MOUNTZ JOHN autoimmunity, immune senescence, gene therapy type I IFNs, IL-23, germinal centers, marginal zone macrophages, inflammatory macrophages, rheumatoid arthritis, lupus   MOUNTZ JOHN autoimmunity, immune senescence, gene therapy type I IFNs, IL-23, germinal centers, marginal zone macrophages, inflammatory macrophages, rheumatoid arthritis, lupus   MOUNTZ JOHN autoimmunity, immune senescence, gene therapy type I IFNs, IL-23, germinal centers, marginal zone macrophages, inflammatory macrophages, rheumatoid arthritis, lupus   MOUNTZ JOHN autoimmunity, immune senescence, gene therapy type I IFNs, IL-23, germinal centers, marginal zone macrophages, inflammatory macrophages, rheumatoid arthritis, lupus   MOUNTZ JOHN autoimmunity, immune senescence, gene therapy type I IFNs, IL-23, germinal centers, marginal zone macrophages, inflammatory macrophages, rheumatoid arthritis, lupus   MOUNTZ JOHN autoimmunity, immune senescence, gene therapy type I IFNs, IL-23, germinal centers, marginal zone macrophages, inflammatory macrophages, rheumatoid arthritis, lupus   MOUNTZ JOHN autoimmunity, immune senescence, gene therapy type I IFNs, IL-23, germinal centers, marginal zone macrophages, inflammatory macrophages, rheumatoid arthritis, lupus   MOUNTZ JOHN autoimmunity, immune senescence, gene therapy type I IFNs, IL-23, germinal centers, marginal zone macrophages, inflammatory macrophages, rheumatoid arthritis, lupus   MOUNTZ JOHN autoimmunity, immune senescence, gene therapy type I IFNs, IL-23, germinal centers, marginal zone macrophages, inflammatory macrophages, rheumatoid arthritis, lupus   MOUNTZ JOHN autoimmunity, immune senescence, gene therapy type I IFNs, IL-23, germinal centers, marginal zone macrophages, inflammatory macrophages, rheumatoid arthritis, lupus   MOUNTZ JOHN autoimmunity, immune senescence, gene therapy type I IFNs, IL-23, germinal centers, marginal zone macrophages, inflammatory macrophages, rheumatoid arthritis, lupus   MOUNTZ JOHN autoimmunity, immune senescence, gene therapy type I IFNs, IL-23, germinal centers, marginal zone macrophages, inflammatory macrophages, rheumatoid arthritis, lupus   MUCCIO DONALD Retinoids for cancer prevention and therapy   MUCCIO DONALD Retinoids for cancer prevention and therapy   MUCCIO DONALD Retinoids for cancer prevention and therapy   MUCCIO DONALD Retinoids for cancer prevention and therapy   MUCCIO DONALD Retinoids for cancer prevention and therapy   MUCCIO DONALD Retinoids for cancer prevention and therapy   MURPHY-ULLRICH JOANNE Extracellular Matrix Control of Cell and Growth Factor Function, multiple myeloma, diabetic complications, glaucoma atherosclerosis, diabetic complications, tumor microenvironment, multiple myeloma, osteolytic bone disease, glaucoma, fibrosis, TGF-beta, thrombospondin   MURPHY-ULLRICH JOANNE Extracellular Matrix Control of Cell and Growth Factor Function, multiple myeloma, diabetic complications, glaucoma atherosclerosis, diabetic complications, tumor microenvironment, multiple myeloma, osteolytic bone disease, glaucoma, fibrosis, TGF-beta, thrombospondin   MURPHY-ULLRICH JOANNE Extracellular Matrix Control of Cell and Growth Factor Function, multiple myeloma, diabetic complications, glaucoma atherosclerosis, diabetic complications, tumor microenvironment, multiple myeloma, osteolytic bone disease, glaucoma, fibrosis, TGF-beta, thrombospondin   MURPHY-ULLRICH JOANNE Extracellular Matrix Control of Cell and Growth Factor Function, multiple myeloma, diabetic complications, glaucoma atherosclerosis, diabetic complications, tumor microenvironment, multiple myeloma, osteolytic bone disease, glaucoma, fibrosis, TGF-beta, thrombospondin   MURPHY-ULLRICH JOANNE Extracellular Matrix Control of Cell and Growth Factor Function, multiple myeloma, diabetic complications, glaucoma atherosclerosis, diabetic complications, tumor microenvironment, multiple myeloma, osteolytic bone disease, glaucoma, fibrosis, TGF-beta, thrombospondin   MURPHY-ULLRICH JOANNE Extracellular Matrix Control of Cell and Growth Factor Function, multiple myeloma, diabetic complications, glaucoma atherosclerosis, diabetic complications, tumor microenvironment, multiple myeloma, osteolytic bone disease, glaucoma, fibrosis, TGF-beta, thrombospondin   MURPHY-ULLRICH JOANNE Extracellular Matrix Control of Cell and Growth Factor Function, multiple myeloma, diabetic complications, glaucoma atherosclerosis, diabetic complications, tumor microenvironment, multiple myeloma, osteolytic bone disease, glaucoma, fibrosis, TGF-beta, thrombospondin   MURPHY-ULLRICH JOANNE Extracellular Matrix Control of Cell and Growth Factor Function, multiple myeloma, diabetic complications, glaucoma atherosclerosis, diabetic complications, tumor microenvironment, multiple myeloma, osteolytic bone disease, glaucoma, fibrosis, TGF-beta, thrombospondin   MURPHY-ULLRICH JOANNE Extracellular Matrix Control of Cell and Growth Factor Function, multiple myeloma, diabetic complications, glaucoma atherosclerosis, diabetic complications, tumor microenvironment, multiple myeloma, osteolytic bone disease, glaucoma, fibrosis, TGF-beta, thrombospondin   MURPHY-ULLRICH JOANNE Extracellular Matrix Control of Cell and Growth Factor Function, multiple myeloma, diabetic complications, glaucoma atherosclerosis, diabetic complications, tumor microenvironment, multiple myeloma, osteolytic bone disease, glaucoma, fibrosis, TGF-beta, thrombospondin   MURPHY-ULLRICH JOANNE Extracellular Matrix Control of Cell and Growth Factor Function, multiple myeloma, diabetic complications, glaucoma atherosclerosis, diabetic complications, tumor microenvironment, multiple myeloma, osteolytic bone disease, glaucoma, fibrosis, TGF-beta, thrombospondin   MURPHY-ULLRICH JOANNE Extracellular Matrix Control of Cell and Growth Factor Function, multiple myeloma, diabetic complications, glaucoma atherosclerosis, diabetic complications, tumor microenvironment, multiple myeloma, osteolytic bone disease, glaucoma, fibrosis, TGF-beta, thrombospondin   MURPHY-ULLRICH JOANNE Extracellular Matrix Control of Cell and Growth Factor Function, multiple myeloma, diabetic complications, glaucoma atherosclerosis, diabetic complications, tumor microenvironment, multiple myeloma, osteolytic bone disease, glaucoma, fibrosis, TGF-beta, thrombospondin   MURPHY-ULLRICH JOANNE Extracellular Matrix Control of Cell and Growth Factor Function, multiple myeloma, diabetic complications, glaucoma atherosclerosis, diabetic complications, tumor microenvironment, multiple myeloma, osteolytic bone disease, glaucoma, fibrosis, TGF-beta, thrombospondin   MURPHY-ULLRICH JOANNE Extracellular Matrix Control of Cell and Growth Factor Function, multiple myeloma, diabetic complications, glaucoma atherosclerosis, diabetic complications, tumor microenvironment, multiple myeloma, osteolytic bone disease, glaucoma, fibrosis, TGF-beta, thrombospondin   MURPHY-ULLRICH JOANNE Extracellular Matrix Control of Cell and Growth Factor Function, multiple myeloma, diabetic complications, glaucoma atherosclerosis, diabetic complications, tumor microenvironment, multiple myeloma, osteolytic bone disease, glaucoma, fibrosis, TGF-beta, thrombospondin   MURPHY-ULLRICH JOANNE Extracellular Matrix Control of Cell and Growth Factor Function, multiple myeloma, diabetic complications, glaucoma atherosclerosis, diabetic complications, tumor microenvironment, multiple myeloma, osteolytic bone disease, glaucoma, fibrosis, TGF-beta, thrombospondin   MURPHY-ULLRICH JOANNE Extracellular Matrix Control of Cell and Growth Factor Function, multiple myeloma, diabetic complications, glaucoma atherosclerosis, diabetic complications, tumor microenvironment, multiple myeloma, osteolytic bone disease, glaucoma, fibrosis, TGF-beta, thrombospondin   MURPHY-ULLRICH JOANNE Extracellular Matrix Control of Cell and Growth Factor Function, multiple myeloma, diabetic complications, glaucoma atherosclerosis, diabetic complications, tumor microenvironment, multiple myeloma, osteolytic bone disease, glaucoma, fibrosis, TGF-beta, thrombospondin   MURPHY-ULLRICH JOANNE Extracellular Matrix Control of Cell and Growth Factor Function, multiple myeloma, diabetic complications, glaucoma atherosclerosis, diabetic complications, tumor microenvironment, multiple myeloma, osteolytic bone disease, glaucoma, fibrosis, TGF-beta, thrombospondin   MURPHY-ULLRICH JOANNE Extracellular Matrix Control of Cell and Growth Factor Function, multiple myeloma, diabetic complications, glaucoma atherosclerosis, diabetic complications, tumor microenvironment, multiple myeloma, osteolytic bone disease, glaucoma, fibrosis, TGF-beta, thrombospondin   MURPHY-ULLRICH JOANNE Extracellular Matrix Control of Cell and Growth Factor Function, multiple myeloma, diabetic complications, glaucoma atherosclerosis, diabetic complications, tumor microenvironment, multiple myeloma, osteolytic bone disease, glaucoma, fibrosis, TGF-beta, thrombospondin   MURPHY-ULLRICH JOANNE Extracellular Matrix Control of Cell and Growth Factor Function, multiple myeloma, diabetic complications, glaucoma atherosclerosis, diabetic complications, tumor microenvironment, multiple myeloma, osteolytic bone disease, glaucoma, fibrosis, TGF-beta, thrombospondin   MURPHY-ULLRICH JOANNE Extracellular Matrix Control of Cell and Growth Factor Function, multiple myeloma, diabetic complications, glaucoma atherosclerosis, diabetic complications, tumor microenvironment, multiple myeloma, osteolytic bone disease, glaucoma, fibrosis, TGF-beta, thrombospondin   MURPHY-ULLRICH JOANNE Extracellular Matrix Control of Cell and Growth Factor Function, multiple myeloma, diabetic complications, glaucoma atherosclerosis, diabetic complications, tumor microenvironment, multiple myeloma, osteolytic bone disease, glaucoma, fibrosis, TGF-beta, thrombospondin   MURPHY-ULLRICH JOANNE Extracellular Matrix Control of Cell and Growth Factor Function, multiple myeloma, diabetic complications, glaucoma atherosclerosis, diabetic complications, tumor microenvironment, multiple myeloma, osteolytic bone disease, glaucoma, fibrosis, TGF-beta, thrombospondin   MURPHY-ULLRICH JOANNE Extracellular Matrix Control of Cell and Growth Factor Function, multiple myeloma, diabetic complications, glaucoma atherosclerosis, diabetic complications, tumor microenvironment, multiple myeloma, osteolytic bone disease, glaucoma, fibrosis, TGF-beta, thrombospondin   MURPHY-ULLRICH JOANNE Extracellular Matrix Control of Cell and Growth Factor Function, multiple myeloma, diabetic complications, glaucoma atherosclerosis, diabetic complications, tumor microenvironment, multiple myeloma, osteolytic bone disease, glaucoma, fibrosis, TGF-beta, thrombospondin   MURPHY-ULLRICH JOANNE Extracellular Matrix Control of Cell and Growth Factor Function, multiple myeloma, diabetic complications, glaucoma atherosclerosis, diabetic complications, tumor microenvironment, multiple myeloma, osteolytic bone disease, glaucoma, fibrosis, TGF-beta, thrombospondin First Prev   25 26 27 28 29 30 31 32 33 34 of  47  Next Last